Gennova in talks with govt to price mRNA vaccine competitively

Since Gennova has the manufacturing-at-risk approval, it has already produced 7 million doses that have been released not only by the company’s in-house quality control but also by the government's nodal Central Drugs Laboratory at Kasauli in Himachal Pradesh, he said. “So as in when the orders come through, we should be able to dispatch these immediately.”

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2xM5lpQ
via IFTTT